Dr. Reddy’s Laboratories has launched Memantine hydrochloride tablets USP, 5 mg and 10 mg, a therapeutic equivalent generic version of NAMENDA® (memantine HCl) tablets in the US market on July 12, 2015.
These tablets have been approved by the United States Food & Drug Administration (USFDA).
Dr. Reddy’s Memantine hydrochloride tablets USP, 5 mg is available in bottle count size of 60 and the Memantine hydrochloride tablets USP, 10 mg are available in bottle count sizes of 60 and 500.
fii-news.com
